The global mantle cell lymphoma therapeutics market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Mantle cell lymphoma is a rare form of B-cell non-Hodgkin lymphoma. It is a form of blood cancer that impacts white blood cells known as lymphocytes. The pivotal factors that are driving the market growth include an increase in the population base suffering from mantle cell lymphoma coupled with the rise in the R&D activities in the healthcare sector resulting in a favorable product pipeline. The global mantle cell lymphoma therapeutics market is majorly driven by the growing number of clinical trials as well as the growing approvals by various governmental agencies. 

Furthermore, approvals for various new drugs by federal agencies is expected to drive the global mantle cell lymphoma treatment market. For instance, in May 2018, the FDA approved AstraZeneca’s Calquence (Acalabrutinib) for relapsed or refractory mantle-cell lymphoma in adults. The mantle cell lymphoma treatment market is also driven by the development of targeted therapy drugs with low toxicity in combination with approved drugs for the treatment of relapsed mantle cell lymphoma. Furthermore, some key players operating in the market include AstraZeneca Plc, Celgene Corp., and Johnson & Johnson Services Inc., among others. 

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered
• Regions Covered- Globally

Competitive Landscape:  AstraZeneca Plc, Celgene Corp., and Johnson & Johnson Services Inc., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Mantle Cell Lymphoma Therapeutics Market by Segment

By Type 

• Combination Therapy

• Monotherapy

By Application 

• Hospital

• Research Institute

• Others

Global Mantle Cell Lymphoma Therapeutics Market by Region